The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Does BPC 157 Cause Erectile Dysfunction? Evidence and Safe Treatments Bolt Pharmacy FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences FDA Moves to Reevaluate Several Peptides American Med Spa Association